Skip to content

Why China‘s new legal framework will be a magnet for global pharmaceuticals

Nick Beckett, managing partner and co-head of CMS Life Sciences & Healthcare Group writes about China’s approach to attracting global pharmaceutical and digital health companies.

Why China‘s new legal framework will be a magnet for global pharmaceuticals
Published: | 2 min read

Nick Beckett, managing partner and co-head of CMS Life Sciences & Healthcare Group writes about China’s approach to attracting global pharmaceutical and digital health companies.

China

China is the world’s second largest healthcare market and it’s growing at a rapid rate. It could become a $1 trillion industry by 2020, according to McKinsey. As a developing country with a huge population, the government needs to ensure its citizens are looked after, and the upcoming challenge is an unprecedented one. By 2050, 80% of the world’s elderly will be Chinese.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information